Intracellular Historical Balance Sheet

ITCI Stock

USD 85.69 0.24 0.28%

Trend analysis of Intracellular Th balance sheet accounts such as Total Current Liabilities of 129.7 M or Total Stockholder Equity of 366.2 M provides information on Intracellular's total assets, liabilities, and equity, which is the actual value of Intracellular Th to its prevalent stockholders. By breaking down trends over time using Intracellular balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Intracellular Th latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Intracellular Th is a good buy for the upcoming year.

Intracellular Inventory

6.18 Million

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Intracellular Th. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

About Intracellular Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Intracellular Th at a specified time, usually calculated after every quarter, six months, or one year. Intracellular Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Intracellular and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Intracellular currently owns. An asset can also be divided into two categories, current and non-current.

Intracellular Balance Sheet Chart

As of now, Intracellular's Total Liabilities is increasing as compared to previous years. The Intracellular's current Property Plant Equipment is estimated to increase to about 3 M, while Total Assets are projected to decrease to under 410.9 M.

Total Assets Other Current Liab Total Current Liabilities Total Stockholder Equity

Add Fundamental

Total Assets

Total assets refers to the total amount of Intracellular assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Intracellular Th books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Intracellular balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Intracellular Th are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Total Stockholder Equity

The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.

Most accounts from Intracellular's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Intracellular Th current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Intracellular Th. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

	2021	2022	2023	2024 (projected)
Other Current Liabilities	37.9M	63.7M	108.5M	113.9M
Total Assets	489.9M	754.8M	728.3M	410.9M

Other Current Liab Total Assets

Intracellular balance sheet Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Accounts Payable	Cash	Other Assets	Common Stock Shares Outstanding	Short Term Investments	Other Current Assets	Total Liab	Common Stock	Property Plant Equipment	Short Long Term Debt Total	Net Tangible Assets	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Retained Earnings Total Equity
Total Assets		0.59	0.63	0.99	0.78	0.66	0.72	0.02	0.9	0.93	0.74	0.67	0.31	0.27	-0.45	0.92	0.65	0.67	-0.61	-0.79	0.55	0.33	0.98	0.54	0.94	-0.82
Other Current Liab	0.59		1.0	0.53	0.59	0.59	0.73	-0.2	0.7	0.36	0.93	0.98	0.38	0.21	-0.76	0.78	0.49	0.49	-0.89	-0.91	0.95	0.89	0.49	0.98	0.68	-0.85
Total Current Liabilities	0.63	1.0		0.57	0.65	0.65	0.77	-0.18	0.75	0.4	0.94	0.99	0.38	0.25	-0.75	0.8	0.54	0.52	-0.9	-0.94	0.94	0.85	0.53	0.96	0.73	-0.89
Total Stockholder Equity	0.99	0.53	0.57		0.74	0.61	0.66	0.05	0.86	0.96	0.69	0.61	0.27	0.24	-0.41	0.92	0.6	0.67	-0.55	-0.74	0.5	0.28	0.99	0.49	0.9	-0.77
Other Liab	0.78	0.59	0.65	0.74		0.87	0.74	0.21	0.89	0.66	0.62	0.71	0.34	0.37	-0.43	0.71	0.71	0.59	-0.61	-0.8	0.59	0.33	0.74	0.47	0.89	-0.83
Accounts Payable	0.66	0.59	0.65	0.61	0.87		0.73	0.27	0.82	0.51	0.62	0.67	0.24	0.32	-0.53	0.6	0.51	0.63	-0.66	-0.74	0.48	0.32	0.61	0.47	0.78	-0.76
Cash	0.72	0.73	0.77	0.66	0.74	0.73		-0.18	0.89	0.45	0.81	0.8	0.28	0.3	-0.69	0.66	0.69	0.62	-0.9	-0.85	0.65	0.43	0.6	0.68	0.85	-0.86
Other Assets	0.02	-0.2	-0.18	0.05	0.21	0.27	-0.18		-0.03	0.15	-0.25	-0.19	-0.09	-0.12	-0.02	-0.02	-0.21	0.09	0.18	0.14	-0.23	-0.18	0.09	-0.25	0.01	0.11
Common Stock Shares Outstanding	0.9	0.7	0.75	0.86	0.89	0.82	0.89	-0.03		0.73	0.82	0.8	0.28	0.45	-0.53	0.82	0.77	0.67	-0.76	-0.9	0.65	0.38	0.83	0.62	0.98	-0.93
Short Term Investments	0.93	0.36	0.4	0.96	0.66	0.51	0.45	0.15	0.73		0.52	0.45	0.19	0.21	-0.24	0.86	0.52	0.63	-0.35	-0.59	0.36	0.15	0.98	0.31	0.79	-0.63
Other Current Assets	0.74	0.93	0.94	0.69	0.62	0.62	0.81	-0.25	0.82	0.52		0.94	0.42	0.34	-0.69	0.84	0.59	0.5	-0.89	-0.95	0.83	0.69	0.64	0.92	0.79	-0.93
Total Liab	0.67	0.98	0.99	0.61	0.71	0.67	0.8	-0.19	0.8	0.45	0.94		0.41	0.3	-0.69	0.81	0.65	0.53	-0.89	-0.97	0.94	0.8	0.58	0.93	0.78	-0.93
Common Stock	0.31	0.38	0.38	0.27	0.34	0.24	0.28	-0.09	0.28	0.19	0.42	0.41		0.21	-0.12	0.27	0.38	-0.2	-0.23	-0.43	0.36	0.25	0.22	0.37	0.4	-0.41
Property Plant Equipment	0.27	0.21	0.25	0.24	0.37	0.32	0.3	-0.12	0.45	0.21	0.34	0.3	0.21		0.06	0.21	0.54	0.22	-0.18	-0.43	0.25	0.01	0.25	0.11	0.43	-0.47
Short Long Term Debt Total	-0.45	-0.76	-0.75	-0.41	-0.43	-0.53	-0.69	-0.02	-0.53	-0.24	-0.69	-0.69	-0.12	0.06		-0.59	-0.06	-0.51	0.87	0.62	-0.61	-0.72	-0.36	-0.78	-0.51	0.56
Net Tangible Assets	0.92	0.78	0.8	0.92	0.71	0.6	0.66	-0.02	0.82	0.86	0.84	0.81	0.27	0.21	-0.59		0.56	0.7	-0.72	-0.86	0.75	0.61	0.91	0.74	0.85	-0.84
Property Plant And Equipment Net	0.65	0.49	0.54	0.6	0.71	0.51	0.69	-0.21	0.77	0.52	0.59	0.65	0.38	0.54	-0.06	0.56		0.41	-0.48	-0.75	0.6	0.18	0.6	0.38	0.77	-0.79
Current Deferred Revenue	0.67	0.49	0.52	0.67	0.59	0.63	0.62	0.09	0.67	0.63	0.5	0.53	-0.2	0.22	-0.51	0.7	0.41		-0.62	-0.58	0.47	0.34	0.69	0.4	0.62	-0.6
Net Debt	-0.61	-0.89	-0.9	-0.55	-0.61	-0.66	-0.9	0.18	-0.76	-0.35	-0.89	-0.89	-0.23	-0.18	0.87	-0.72	-0.48	-0.62		0.86	-0.77	-0.69	-0.51	-0.87	-0.71	0.83
Retained Earnings	-0.79	-0.91	-0.94	-0.74	-0.8	-0.74	-0.85	0.14	-0.9	-0.59	-0.95	-0.97	-0.43	-0.43	0.62	-0.86	-0.75	-0.58	0.86		-0.87	-0.65	-0.71	-0.85	-0.89	0.99
Non Current Assets Total	0.55	0.95	0.94	0.5	0.59	0.48	0.65	-0.23	0.65	0.36	0.83	0.94	0.36	0.25	-0.61	0.75	0.6	0.47	-0.77	-0.87		0.9	0.47	0.9	0.66	-0.8
Non Currrent Assets Other	0.33	0.89	0.85	0.28	0.33	0.32	0.43	-0.18	0.38	0.15	0.69	0.8	0.25	0.01	-0.72	0.61	0.18	0.34	-0.69	-0.65	0.9		0.24	0.89	0.39	-0.54
Cash And Short Term Investments	0.98	0.49	0.53	0.99	0.74	0.61	0.6	0.09	0.83	0.98	0.64	0.58	0.22	0.25	-0.36	0.91	0.6	0.69	-0.51	-0.71	0.47	0.24		0.43	0.87	-0.75
Net Receivables	0.54	0.98	0.96	0.49	0.47	0.47	0.68	-0.25	0.62	0.31	0.92	0.93	0.37	0.11	-0.78	0.74	0.38	0.4	-0.87	-0.85	0.9	0.89	0.43		0.6	-0.78
Common Stock Total Equity	0.94	0.68	0.73	0.9	0.89	0.78	0.85	0.01	0.98	0.79	0.79	0.78	0.4	0.43	-0.51	0.85	0.77	0.62	-0.71	-0.89	0.66	0.39	0.87	0.6		-0.91
Retained Earnings Total Equity	-0.82	-0.85	-0.89	-0.77	-0.83	-0.76	-0.86	0.11	-0.93	-0.63	-0.93	-0.93	-0.41	-0.47	0.56	-0.84	-0.79	-0.6	0.83	0.99	-0.8	-0.54	-0.75	-0.78	-0.91

Click cells to compare fundamentals

Intracellular Account Relationship Matchups

Intracellular balance sheet Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	251.2M	717.3M	489.9M	754.8M	728.3M	410.9M
Other Current Liab	25.6M	25.8M	37.9M	63.7M	108.5M	113.9M
Total Current Liabilities	36.2M	36.9M	53.4M	83.2M	123.5M	129.7M
Total Stockholder Equity	195.0M	656.9M	417.9M	656.1M	591.4M	366.2M
Accounts Payable	7.4M	5.5M	8.7M	10.4M	11.5M	6.4M
Cash	107.6M	60.0M	92.4M	148.6M	147.8M	74.0M
Other Assets	608.1K	350.7K	86.1K	86K	98.9K	94.0K
Common Stock Shares Outstanding	55.2M	70.4M	81.3M	94.0M	95.9M	55.1M
Short Term Investments	116.4M	597.4M	320.0M	443.3M	350.2M	287.1M
Other Current Assets	6.3M	15.6M	26.8M	46.9M	42.4M	44.6M
Total Liab	56.2M	60.5M	72.0M	98.7M	136.9M	143.7M
Common Stock	5.6K	8.0K	8.2K	9K	10K	6.6K
Property Plant Equipment	2.3M	2.0M	22.6M	1.9M	2.2M	3.0M
Net Tangible Assets	195.0M	656.9M	417.9M	656.1M	754.5M	792.2M
Property Plant And Equipment Net	20.5M	26.3M	22.6M	16.7M	14.6M	9.6M
Net Debt	(84.5M)	(30.9M)	(67.0M)	(128.6M)	(130.8M)	(124.3M)
Retained Earnings	(710.1M)	(937.1M)	(1.2B)	(1.5B)	(1.6B)	(1.5B)
Non Current Assets Total	20.9M	26.4M	22.6M	16.8M	60.5M	63.5M
Cash And Short Term Investments	224.0M	657.4M	412.3M	591.9M	497.9M	388.7M
Common Stock Total Equity	5.6K	8.0K	8.2K	9K	10.4K	5.5K
Retained Earnings Total Equity	(710.1M)	(937.1M)	(1.2B)	(1.5B)	(1.3B)	(1.3B)
Liabilities And Stockholders Equity	251.2M	717.3M	489.9M	754.8M	728.3M	443.0M
Non Current Liabilities Total	20.0M	23.6M	18.7M	15.5M	13.3M	10.0M
Capital Surpluse	905.0M	1.6B	1.6B	2.1B	2.5B	2.6B
Other Stockholder Equity	905.0M	1.6B	1.6B	2.1B	2.2B	2.3B
Property Plant And Equipment Gross	20.5M	26.3M	1.8M	1.9M	14.6M	15.3M
Total Current Assets	230.3M	690.9M	467.3M	738.0M	667.8M	428.9M
Accumulated Other Comprehensive Income	128.3K	480.6K	(363.7K)	(4.2M)	104K	109.2K
Net Invested Capital	195.0M	656.9M	417.9M	656.1M	591.4M	516.9M
Net Working Capital	194.1M	654.1M	413.9M	654.7M	544.3M	508.4M
Capital Stock	5.6K	8.0K	8.2K	9K	10K	8.5K

Currently Active Assets on Macroaxis

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America
S	SentinelOne
WD	Walker Dunlop

When determining whether Intracellular Th offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Intracellular's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Intracellular Th Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Intracellular Th Stock:

How To Invest In Intracellular

Details

Is Intracellular Stock a good investment?

Details

What is Intracellular's Net Worth?

Details

Largest Pharmaceuticals Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

You can also try the CEOs Directory module to screen CEOs from public companies around the world.

Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Intracellular. If investors know Intracellular will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Intracellular listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(0.87)

Revenue Per Share

6.096

Quarterly Revenue Growth

0.39

Return On Assets

(0.07)

Return On Equity

(0.1)

The market value of Intracellular Th is measured differently than its book value, which is the value of Intracellular that is recorded on the company's balance sheet. Investors also form their own opinion of Intracellular's value that differs from its market value or its book value, called intrinsic value, which is Intracellular's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Intracellular's market value can be influenced by many factors that don't directly affect Intracellular's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Intracellular's value and its price as these two are different measures arrived at by different means. Investors typically determine if Intracellular is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Intracellular's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Intracellular Historical Balance Sheet

Intracellular Inventory

6.18 Million

About Intracellular Balance Sheet Analysis

Intracellular Balance Sheet Chart

Total Assets

Total Current Liabilities

Total Stockholder Equity

Intracellular balance sheet Correlations

Intracellular Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Intracellular balance sheet Accounts

Currently Active Assets on Macroaxis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Current Liabilities	+ 1.0	Other Current Liab
Total Stockholder Equity	+ 0.99	Total Assets
Total Liab	+ 0.99	Total Current Liabilities
Cash And Short Term Investments	+ 0.99	Total Stockholder Equity
Retained Earnings Total Equity	+ 0.99	Retained Earnings
Cash And Short Term Investments	+ 0.98	Total Assets

Retained Earnings	- 0.97	Total Liab
Retained Earnings	- 0.95	Other Current Assets
Retained Earnings	- 0.94	Total Current Liabilities
Retained Earnings Total Equity	- 0.93	Total Liab
Retained Earnings Total Equity	- 0.93	Other Current Assets
Retained Earnings Total Equity	- 0.93	Common Stock Shares Outstanding